Graph Blockchain Inc. (CSE:GBLC) (“Graph” or the “Company”) announces it has entered into a binding letter of intent (“LOI”) in connection with the proposed acquisition of Third Eye Insights Corp. (“Third Eye” or “Seller”), to acquire 100% of all issued and outstanding shares of Third Eye (the “Third Eye Shares”), a corporation established pursuant to the Business Corporations Act (British Columbia) by way of: (i) an amalgamation, or (ii) any other form of business combination to be determined by the legal and tax advisors of the respective parties, acting reasonably (the “Proposed Transaction”).
Christian Scovenna, CEO of Graph Blockchain comments, “This acquisition of Third Eye is a great direction for the company and our shareholders. The AI technology of Third Eye’s deep analytics platform will allow our ecommerce marketplace BluStem to capture and visualize a vast amount of consumer data. This will allow BluStem to understand target audiences in real-time, and make better decisions by pinpointing specific trends, risks and opportunities when selling various Wellness brands and products.”
Key Transaction Terms:
- Subject to the terms and conditions of the LOI, Graph Blockchain Inc. (the “Acquirer”) intends to acquire all of the issued and outstanding share capital of Seller pursuant to the following terms:
- The LOI contemplates that the consideration for the Proposed Transaction will consist of an aggregate of 120 million common shares in the capital of Graph Blockchain Inc. to be issued at a deemed price of $0.02 per share for aggregate consideration of $2.4M Cdn dollar value of the Proposed Transaction (the “Common Shares”).
- The LOI is subject to completion of formal due diligence, execution of a definitive agreement in connection with the Proposed Transaction, receipt of all regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”), approval of the board of directors of both the Seller and the Company and, such other conditions customary for a transaction of this nature. There is no assurance that the Proposed Transaction will be completed in the manner presently proposed or at all.
Closing of the Proposed Transaction is currently expected to occur on or about Aug 31st, 2020 (the “Acquisition Closing”). or such other date as mutually agreed to by the parties.
About Third Eye Insights Corp.
Third Eye Insights Corp. is a private British Columbia corporation that provides a cloud-based analytics platform using AI to cleanse and analyze data-intensive information helping the alternative medicines industry, while also analyzing trends, critical social data in the recreational and medicinal sectors. Third Eye’s deep analytics platform captures, structures, and visualizes vast amounts of unstructured social media data which, used as a discovery tool, allows organizations to understand target audiences in real time to help make better decisions by pinpointing specific trends, risks and opportunities taking place.
Additional Information on Third Eye is available at www.thirdeyecorp.com
About Graph Blockchain Inc.
The Company develops leading-edge private blockchain business intelligence and data management solutions that it will implement into a blockchain supported e-commerce marketplace for the sale of psychedelic and ancillary products in legal jurisdictions.
Additional Information on the Company & eCommerce Marketplace is available at:
For further information, please contact:
Christian Scovenna – President & CEO
Phone: (416) 453-4708
Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Such statements may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).